Design and validity of a clinic-based case-control study on the molecular epidemiology of lymphoma
about
Associations of non-Hodgkin Lymphoma (NHL) risk with autoimmune conditions according to putative NHL lociA meta-analysis of Hodgkin lymphoma reveals 19p13.3 TCF3 as a novel susceptibility locusAllergic conditions are not associated with the risk of non-Hodgkin's lymphoma or Hodgkin's lymphoma: a systematic review and meta-analysisMedical history, lifestyle, family history, and occupational risk factors for lymphoplasmacytic lymphoma/Waldenström's macroglobulinemia: the InterLymph Non-Hodgkin Lymphoma Subtypes Project.Rationale and Design of the International Lymphoma Epidemiology Consortium (InterLymph) Non-Hodgkin Lymphoma Subtypes ProjectElevated soluble IL-2Rα, IL-8, and MIP-1β levels are associated with inferior outcome and are independent of MIPI score in patients with mantle cell lymphomaElevated serum levels of IL-2R, IL-1RA, and CXCL9 are associated with a poor prognosis in follicular lymphoma.Non-Hodgkin Lymphoma, Body Mass Index, and Cytokine Polymorphisms: A Pooled Analysis from the InterLymph Consortium.Food-frequency questionnaire-based estimates of total antioxidant capacity and risk of non-Hodgkin lymphoma.Elevated pretreatment serum levels of interferon-inducible protein-10 (CXCL10) predict disease relapse and prognosis in diffuse large B-cell lymphoma patients.A two-stage evaluation of genetic variation in immune and inflammation genes with risk of non-Hodgkin lymphoma identifies new susceptibility locus in 6p21.3 region.Pretreatment circulating serum cytokines associated with follicular and diffuse large B-cell lymphoma: a clinic-based case-control studyComprehensive serum cytokine analysis identifies IL-1RA and soluble IL-2Rα as predictors of event-free survival in T-cell lymphomaThe association between early life and adult body mass index and physical activity with risk of non-Hodgkin lymphoma: impact of gender.Early life sun exposure, vitamin D-related gene variants, and risk of non-Hodgkin lymphoma.Mapping of the IRF8 gene identifies a 3'UTR variant associated with risk of chronic lymphocytic leukemia but not other common non-Hodgkin lymphoma subtypes.Tumor necrosis factor-308 polymorphism with the risk and prognosis of non-Hodgkin lymphomas: a meta-analysis studyRisk of non-hematologic cancer in individuals with high-count monoclonal B-cell lymphocytosis.Single-nucleotide polymorphism rs1052501 associated with monoclonal gammopathy of undetermined significance and multiple myelomaTrans fatty acid intake is associated with increased risk and n3 fatty acid intake with reduced risk of non-hodgkin lymphomaCXCR5 polymorphisms in non-Hodgkin lymphoma risk and prognosis.Genome-wide association analysis implicates dysregulation of immunity genes in chronic lymphocytic leukaemia.Elevated serum monoclonal and polyclonal free light chains and interferon inducible protein-10 predicts inferior prognosis in untreated diffuse large B-cell lymphoma.Cohort Profile: The Lymphoma Specialized Program of Research Excellence (SPORE) Molecular Epidemiology Resource (MER) Cohort Study.
P2860
Q28083556-D6AD2D0B-5658-458D-81A0-ED9AA1DD81C7Q28943487-6809377E-0859-46D3-AE61-075AF3E59C7DQ33596923-5C73EF1B-9602-4046-AD0A-2D64F4F3426BQ34137888-40868EB6-2B59-4EFF-A3DD-94A42F71BFD9Q34137915-0D5C0EC4-8F1C-49AD-94DF-8B94007D810BQ34626318-E6100CF7-A82A-4DA2-A6C3-13E57FA6CDFCQ35056309-A9D2B93E-DE91-4BCF-935A-2636FDFA95F8Q35815614-CF3CBD5B-66D7-433F-9EC1-A7C78BED3D95Q35836638-8B50C582-7FD0-4391-B9CA-9A1A64797259Q36195016-30BDE21A-41D6-432A-BB24-9C7FFDBF20B5Q36306403-96A53AE0-1E7E-43D8-94EB-5D4767681975Q36354265-C0CA92AC-61E6-4FB5-8CF7-FF8519345129Q36384484-430DDBEB-1A0E-44FE-8EAC-60E9D293B22CQ36443311-B7D6DA8B-9E33-4B5C-9B9C-8AEC06CCA238Q36660850-5AF0E317-90A1-4F43-A6DF-782DBC959053Q36680976-33DAD7A4-E353-463A-B072-8D38DB30C127Q36729256-B92ABC04-3C5E-4883-8EEA-7697DF3FA61DQ36822986-8202133A-9E96-476A-87EB-209920B46EEBQ36999599-DB46696F-DDC5-483C-9418-DD065777EBD3Q37082267-A93F09B4-3CF6-4BC6-9EB2-C64182D26D5DQ37135341-51639A66-C21B-49EB-A674-0A1628CE9D53Q37637724-51291E05-B3E8-4ED9-9086-343C2DC0452BQ39037933-A150D11A-9EA1-4A4A-A06B-28156DF83742Q50099990-B567ECC5-26DE-442D-9229-D9D871088C2A
P2860
Design and validity of a clinic-based case-control study on the molecular epidemiology of lymphoma
description
2011 nî lūn-bûn
@nan
2011 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Design and validity of a clini ...... cular epidemiology of lymphoma
@ast
Design and validity of a clini ...... cular epidemiology of lymphoma
@en
type
label
Design and validity of a clini ...... cular epidemiology of lymphoma
@ast
Design and validity of a clini ...... cular epidemiology of lymphoma
@en
prefLabel
Design and validity of a clini ...... cular epidemiology of lymphoma
@ast
Design and validity of a clini ...... cular epidemiology of lymphoma
@en
P2093
P2860
P1476
Design and validity of a clini ...... cular epidemiology of lymphoma
@en
P2093
Alice H Wang
Julie M Cunningham
Mark Liebow
Neil E Kay
Stephen M Ansell
Susan L Slager
Tait D Shanafelt
Thomas E Witzig
Thomas M Habermann
Timothy G Call
P2860
P304
P577
2011-04-05T00:00:00Z